Sana Biotechnology SANA Income Statement (2020-2026)

NASDAQ SANA
$2.43 -0.03 (-1.42%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Sana Biotechnology Quarterly Income Statement

Periods 27 quarters
Latest Sep 2026

Sana Biotechnology reported revenue of $1.22M and net income of $18.51M for the quarter ended Sep 2026, up 21.5% year over year. This income statement covers 27 quarters of results from Mar 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
0.27M0.34M0.64M1.17M1.61M1.98M2.37M2.86M2.73M3.03M3.20M2.58M1.66M0.99M0.58M1.00M1.28M0.95M1.13M1.22M
Operating items
Research & DevelopmentR&D
108.51M72.69M72.54M76.74M63.92M67.17M73.04M65.61M55.99M56.45M60.87M53.21M45.15M37.19M29.76M30.11M34.92M28.72M30.73M33.93M
Selling, General & AdministrativeSG&A
12.68M14.43M18.29M15.51M23.32M16.77M16.57M19.18M20.78M16.27M16.44M14.05M17.28M11.48M10.34M10.29M12.19M11.46M10.78M10.94M
Other Operating ExpensesOther Opex
-9.91M-55.44M-17.93M-6.06M-5.45M0.12M26.68M-82.62M13.85M38.01M-27.94M-5.50M-11.56M1.96M54.87M3.12M14.09M8.43M23.91M-63.38M
Operating ExpensesOpex
111.28M31.69M72.90M86.19M81.79M84.05M116.29M2.18M90.62M110.72M49.37M61.76M50.87M50.63M94.98M43.52M61.20M48.61M65.42M-18.51M
Operating IncomeOp. Inc
-111.28M-31.69M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.98M-43.52M-61.20M-48.61M-65.42M18.51M
Non-operating items
Other Non Operating IncomeOther Non Op Inc.
0.28M-0.10M-0.20M-0.11M-0.27M-0.05M-0.08M0.30M-0.22M0.22M-4.12M-0.74M0.14M0.25M0.60M0.36M1.10M0.45M0.66M0.68M
Net income details
EBIT
-111.28M-31.69M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.98M-43.52M-61.20M-48.61M-65.42M18.51M
EBT
-111.28M-31.69M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.98M-43.52M-61.20M-48.61M-65.42M18.51M
Income After Tax
-111.28M-31.69M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.98M-43.52M-61.20M-48.61M-65.42M18.51M
Income from Continuing OperationsIncome (Continuing)
-111.28M-31.69M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.98M-43.52M-61.20M-48.61M-65.42M18.51M
Consolidated Net IncomeConsol Net Inc.
-111.28M-31.69M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.98M-43.52M-61.20M-48.61M-65.42M18.51M
Income towards Parent CompanyParent Net Inc
-110.73M-31.45M-72.47M-85.12M-80.44M-82.12M-114.00M0.98M-88.12M-107.48M-50.29M-59.92M-49.07M-49.39M-93.80M-42.15M-58.83M-47.21M-63.64M20.40M
Net Income towards Common StockholdersNet Income
-110.73M-31.45M-72.47M-85.12M-80.44M-82.12M-114.00M0.98M-88.12M-107.48M-50.29M-59.92M-49.07M-49.39M-93.80M-42.15M-58.83M-47.21M-63.64M20.40M
Additional items
EPS (Basic)
-0.67-0.17-0.39-0.45-0.43-0.43-0.590.00-0.45-0.49-0.21-0.25-0.21-0.21-0.39-0.16-0.23-0.17-0.220.07
EPS (Diluted)
-0.67-0.17-0.39-0.45-0.43-0.43-0.590.00-0.45-0.49-0.21-0.25-0.21-0.21-0.39-0.16-0.23-0.17-0.220.07
Shares Outstanding
166.43M185.96M187.63M189.30M188.34M191.23M192.54M196.98M194.54M217.29M234.44M235.41M230.89M237.58M238.41M260.49M253.23M276.86M295.67M307.00M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
166.43M185.96M187.63M189.30M188.34M191.23M192.54M200.47M194.54M217.29M234.44M235.41M230.89M237.58M238.41M260.49M253.23M276.86M295.67M308.79M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
184.93M186.63M188.43M189.90M191.02M191.41M196.88M197.06M197.86M221.29M222.21M223.11M223.92M225.46M230.51M262.26M266.73M269.82M299.31M299.63M
EBITDA
-107.91M-28.07M-69.10M-82.19M-77.59M-79.71M-111.79M2.32M-86.38M-106.98M-45.47M-57.66M-47.07M-46.98M-92.08M-40.32M-58.10M-46.21M-63.22M21.51M

Sana Biotechnology Income Statement API

Pull Sana Biotechnology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SANA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY